Phio Pharmaceuticals Corp. (PHIO) Misses Q1 EPS by 41c
Tweet
Share
E-mailGet Alerts PHIO Hot Sheet
Join SI Premium – FREE
Phio Pharmaceuticals Corp. (NASDAQ: PHIO) reported Q1 EPS of ($0.41).
For earnings history and earnings-related data on Phio Pharmaceuticals Corp. (PHIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Goldman Sachs Reinstates BlueScope Steel Limited (BSL:AU) (BLSFY) at Buy
- Csquare targets up to $1.35 billion in US initial offering
- Latham Group (SWIM) Reiterated at Buy by Stifel on Top-Tier Growth Potential
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
